6Sunagawa, M. , Itoh, M. , Kubota, Ky et al. New anti-MRSA and anti-VRE carbapenems: Synthesis and structure-activity relationships of lp-metyl-2-( thiazol-2-ylthio)carbapenems[ J]. J Antibiot,2002,55 (8):722-757.
9Abraham DJ,Burger's Medicinal Chemistiy and Drug Discovery[M].6th,Vol 5 ,New Zealand:John Wiley&Sons. Inc. ,2003,607-737.
10Kurazono M, Ida T, Yamada K, et al. In vitro activities of ME1036(CP5609) ,a novel parenteral caapenem, against methicillin-resist-ant staphylococci ( J ]. Antimicrob Agents Chemother, 2004,48 (8):2831-2837.
1Curcio D.Multidrug-resistant Gram-negative bacterial infections:are you ready for the challenge[J].Curr Clin Pharmacol,2014,9(1):27-38.
2Al-niemat SI,Bloukh DT,Al-harasis MD,et al.Drugs use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicatiors[J].Saudi Med J,2008,29(5):743-748.
3ASHP.ASHP guidelines on the pharmacist’s role in drug use evaluation[J].Am J Hosp Pharm,1988,45(2):385.
4National Prescribing Service Limited.Drug use evaluation antipsychotic use in the management of dementia in aged care homes[S].2007:1.
5SabatéM,Ferrer P,Ballarín E,et al.Inpatient Drug Utilization in Europe:Nationwide data sources and a review of publications on a selected group of medicines(PROTECT Project)[J].Basic Clin Pharmacol Toxicol,2015,116(3):201-211.
6Thha FA,Hammond DN,Sheth RD.Seizures from valproate-carbapenem interaction[J].Pediatr Neurol,2013,49(4):279-281.
